Previous 10 | Next 10 |
2024-02-07 18:54:03 ET Inotiv, Inc. (NOTV) Q1 2024 Earnings Conference Call February 7, 2024, 4:30 PM ET Company Participants Bob Yedid - Investor Relations Bob Leasure - President and CEO Beth Taylor - Chief Financial Officer Conference Call Participants ...
2024-02-07 16:17:40 ET More on Inotiv Inotiv: The Business Is Recovering, The Stock Will Follow Inotiv, Inc. (NOTV) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Inotiv Historical earnings data for Inotiv Financial informatio...
- First quarter fiscal 2024 revenue up 10.3% to $135.5 million - First quarter fiscal 2024 DSA revenue up 8.8% to $44.7 million and RMS revenue up 11.1% to $90.8 million - Shift to a renewed focus on sales and marketing as near-term infrastructure projects near completion -&...
Penske Automotive Group Inc. (PAG) is expected to report $3.66 for Q4 2023 Copa Holdings S.A. Class A (CPA) is expected to report $3.9 for Q4 2023 Wynn Resorts Limited (WYNN) is expected to report $1.12 for Q4 2023 U-Haul Holding Co Com (UHAL) is expected to report $0.82 for Q3 2024 ...
WEST LAFAYETTE, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rel...
2024-01-04 12:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting December 2023 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling...
2023-12-11 19:45:22 ET Inotiv, Inc. (NOTV) Q4 2023 Earnings Conference Call December 11, 2023 04:30 PM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Bob Leasure - Chief Executive Officer, President, and Director Beth Taylor - Senior Vic...
2023-12-11 16:17:15 ET More on Inotiv Seeking Alpha’s Quant Rating on Inotiv Historical earnings data for Inotiv Financial information for Inotiv For further details see: Inotiv GAAP EPS of -$0.38 misses by $0.05, revenue of $140.74M beats by $1.31M
— Fiscal year 2023 revenue up 4.5% to $572.4 million, achieving full year revised guidance — Achievements in the past fiscal year to expand DSA capacity, develop new services and reduce outsourcing expected to drive continued growth of fiscal 2024 DSA revenues ...
Lanvin Group Holdings Limited (LANV) is expected to report for quarter end 2023-09-30 Sonnet BioTherapeutics Holdings Inc. (SONN) is expected to report for Q4 2023 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q2 2024 Gelesis Holdings, Inc. (GLSHQ) is expected to repor...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...